ATE180493T1 - Rezeptor für 6(r)-l-erythro-5,6,7,8- tetrahydrobiopterin - Google Patents

Rezeptor für 6(r)-l-erythro-5,6,7,8- tetrahydrobiopterin

Info

Publication number: ATE180493T1
Authority: AT; Austria
Prior art keywords: binding; tetrahydrobiopterin; erythro; receptor; capacity
Prior art date: 1991-11-16

Application number

AT92923528T

Other languages

English (en)

Inventor

Yasuyoshi Watanabe

Yumiko Watanabe

Hiroshi Morii

Toshio Hayashi

Original Assignee

Suntory Ltd

Osaka Bioscience Inst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-11-16

Filing date

1992-11-16

Publication date

1999-06-15

1992-11-16 Application filed by Suntory Ltd, Osaka Bioscience Inst filed Critical Suntory Ltd

1999-06-15 Application granted granted Critical

1999-06-15 Publication of ATE180493T1 publication Critical patent/ATE180493T1/de

Links

FNKQXYHWGSIFBK-RPDRRWSUSA-N sapropterin Chemical compound N1=C(N)NC(=O)C2=C1NC[C@H]([C@@H](O)[C@@H](O)C)N2 FNKQXYHWGSIFBK-RPDRRWSUSA-N 0.000 abstract 3
UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 abstract 2
239000012528 membrane Substances 0.000 abstract 2
206010003805 Autism Diseases 0.000 abstract 1
208000020706 Autistic disease Diseases 0.000 abstract 1
102000014914 Carrier Proteins Human genes 0.000 abstract 1
206010029333 Neurosis Diseases 0.000 abstract 1
YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 abstract 1
102000004142 Trypsin Human genes 0.000 abstract 1
108090000631 Trypsin Proteins 0.000 abstract 1
210000001557 animal structure Anatomy 0.000 abstract 1
108091008324 binding proteins Proteins 0.000 abstract 1
210000000172 cytosol Anatomy 0.000 abstract 1
239000002808 molecular sieve Substances 0.000 abstract 1
208000015238 neurotic disease Diseases 0.000 abstract 1
URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 abstract 1
229910052722 tritium Inorganic materials 0.000 abstract 1
239000012588 trypsin Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Toxicology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Cell Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)
Peptides Or Proteins (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Enzymes And Modification Thereof (AREA)

AT92923528T 1991-11-16 1992-11-16 Rezeptor für 6(r)-l-erythro-5,6,7,8- tetrahydrobiopterin ATE180493T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP30089491		1991-11-16

Publications (1)

Publication Number	Publication Date
ATE180493T1 true ATE180493T1 (de)	1999-06-15

Family

ID=17890406

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92923528T ATE180493T1 (de)	1991-11-16	1992-11-16	Rezeptor für 6(r)-l-erythro-5,6,7,8- tetrahydrobiopterin

Country Status (5)

Country	Link
US (1)	US5606020A (de)
EP (1)	EP0592673B1 (de)
AT (1)	ATE180493T1 (de)
DE (1)	DE69229270D1 (de)
WO (1)	WO1993010155A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0722731B1 (de) *	1994-08-05	2002-06-05	Suntory Limited	Arzneimittel gegen spinocerebellare degeneration
PL1708690T3 (pl)	2003-11-17	2017-01-31	Biomarin Pharmaceutical Inc.	Leczenie fenyloketonurii za pomocą BH4
AU2005259961B2 (en) *	2004-06-25	2012-05-17	Board Of Regents, The University Of Texas System	Methods and compositions for the treatment of attention deficit hyperactivity disorder and hyperphenylalanemia
KR20070084270A (ko) *	2004-11-17	2007-08-24	바이오마린 파머수티컬 인크.	안정한 정제 제형물
US9216178B2 (en)	2011-11-02	2015-12-22	Biomarin Pharmaceutical Inc.	Dry blend formulation of tetrahydrobiopterin

1992
- 1992-11-16 AT AT92923528T patent/ATE180493T1/de active
- 1992-11-16 WO PCT/JP1992/001496 patent/WO1993010155A1/ja not_active Ceased
- 1992-11-16 EP EP92923528A patent/EP0592673B1/de not_active Expired - Lifetime
- 1992-11-16 DE DE69229270T patent/DE69229270D1/de not_active Expired - Lifetime
- 1992-11-16 US US08/087,802 patent/US5606020A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU2930892A (en)	1993-06-15
EP0592673A1 (de)	1994-04-20
EP0592673B1 (de)	1999-05-26
WO1993010155A1 (fr)	1993-05-27
DE69229270D1 (en)	1999-07-01
US5606020A (en)	1997-02-25
AU668117B2 (en)	1996-04-26
EP0592673A4 (de)	1994-04-27

Similar Documents

Publication	Publication Date	Title
ATE133564T1 (de)	1996-02-15	Flupirtin in kombination mit antiparkinsonika zur bekämpfung von muskelverspannungen
DE69232137D1 (de)	2001-11-22	Multivalente antigen-bindende proteine
TR200003650T2 (tr)	2001-08-21	ß2-adrenerjik reseptör agonistleri
DK0397633T3 (da)	1996-01-02	Fibronectinbindende protein samt fremstilling deraf
ATE239797T1 (de)	2003-05-15	Antikörper gegen beta-amyloid oder derivative davon und seine verwendung
TR25502A (tr)	1993-05-01	Gida maddeleri ve hayvan yemleri icin phospholipo protein ihtiva eden bilesenler
MX163822B (es)	1992-06-23	Concentrado de proteina de arroz soluble
DE69232693D1 (de)	2002-08-29	Glialmitogene faktoren, ihre herstellung und verwendung
DK0754229T3 (da)	1999-07-19	Afamin: et humant serum albumin-lignende protein
NZ332954A (en)	2000-07-28	Use of BPI protein products to treat humans with hemorrhage due to trauma
IL145310A0 (en)	2003-01-12	Vascular adhesion molecules and modulation of their function
ATE180493T1 (de)	1999-06-15	Rezeptor für 6(r)-l-erythro-5,6,7,8- tetrahydrobiopterin
GB9606040D0 (en)	1996-05-22	Active peptide
DK1431391T3 (da)	2005-12-19	RANTES-mutanter og terapeutiske anvendelser heraf
SE9003374D0 (sv)	1990-10-22	A collagen binding protein as well as its preparation
ATE113591T1 (de)	1994-11-15	4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.
IT239103Y1 (it)	2001-02-19	Supporto, particolarmente per filtri, gomme o slitte atti e/o adessere fissati sul fondo dellle gambe o piedini di mobili, sedie
ATE147106T1 (de)	1997-01-15	Anti-oncostatin-m monoklonale antikörper
DE58906618D1 (de)	1994-02-17	Strobilurinderivate, ihre Herstellung und Verwendung.
ATE231001T1 (de)	2003-02-15	Verwendung von protein c inhibitor zur behandlung disseminierter intravasaler gerinnung (dic)
ATE173088T1 (de)	1998-11-15	Verfahren zum nachweis von alzheimer-krankheit
GB9120037D0 (en)	1991-11-06	Immunological control of fat
Ledbetter et al.	1993	EVALUATION OF PAKISTANI APRICOT GERMPLASM FOR POTENTIAL AS BREEDING MATERIAL OR CULTIVARS IN THE CENTRAL SAN JOAQUIN VALLEY
周晓海 et al.	1996	Kinetic studies on oxygen binding to dicobalt (Ⅱ) diporphyrin
ES1027843U (es)	1994-10-16	Zapatilla-funda extensible para zapatos.